What is the difference between antiplatelet and anti coagulation?


Author: Succeeder    

Anticoagulation is the process of reducing fibrin thrombus formation through the application of anticoagulant drugs to reduce the process of intrinsic pathway and intrinsic coagulation pathway.

Anti-platelet medicine is to take anti-platelet drugs to reduce the adhesion and aggregation function of platelets, thereby reducing the process of platelet thrombus formation. In clinical practice, commonly used anticoagulant drugs include warfarin and heparin, which reduce the possibility of fibrinogen thrombus formation through different anticoagulant pathways. For example, warfarin is often used in anticoagulant therapy after heart valve surgery, and heparin is often used in the treatment of lower extremity venous thrombosis.

Common antiplatelet drugs include aspirin, Plavix, etc. These drugs can prevent platelet aggregation through different links, thereby preventing the formation of platelet thrombus. Clinically, it is used for the prevention of coronary heart disease, cerebral thrombosis and other diseases.

Beijing SUCCEEDER as one of the leading brands in China Diagnostic market of Thrombosis and Hemostasis, SUCCEEDER has experienced teams of R&D,Production,Marketing Sales and Service Supplying coagulation analyzers and reagents, blood rheology analyzers, ESR and HCT analyzers, platelet aggregation analyzers with ISO13485,CE Certification and FDA listed.